These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8737004)

  • 1. Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.
    Lejoyeux M
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():69-75. PubMed ID: 8737004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.
    Lejoyeux M
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):69-75. PubMed ID: 9845041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of serotonin (5-HT) and opiate-based drugs in the pharmacotherapy of alcohol dependence: an overview of the preclinical data.
    Lê AD; Tomkins DM; Sellers EM
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():27-32. PubMed ID: 8736998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The status of serotonin-selective pharmacotherapy in the treatment of alcohol dependence.
    Pettinati HM; Kranzler HR; Madaras J
    Recent Dev Alcohol; 2003; 16():247-62. PubMed ID: 12638641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety and alcoholism: a serotonin link.
    Tollefson GD
    Br J Psychiatry Suppl; 1991 Sep; (12):34-9. PubMed ID: 1840761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin's Complex Role in Alcoholism: Implications for Treatment and Future Research.
    Marcinkiewcz CA; Lowery-Gionta EG; Kash TL
    Alcohol Clin Exp Res; 2016 Jun; 40(6):1192-201. PubMed ID: 27161942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy in alcoholism treatment: integrating and understanding the use of serotonin reuptake inhibitors.
    George FR
    Alcohol Alcohol Suppl; 1994; 2():537-43. PubMed ID: 8974380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of serotonin-altering medications for decreasing alcohol consumption.
    Naranjo CA; Bremner KE
    Alcohol Alcohol Suppl; 1993; 2():221-9. PubMed ID: 7748304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin-altering medications and desire, consumption and effects of alcohol-treatment implications.
    Naranjo CA; Bremner KE
    EXS; 1994; 71():209-19. PubMed ID: 8032152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of selective serotonin reuptake inhibitors in reducing alcohol consumption.
    Naranjo CA; Knoke DM
    J Clin Psychiatry; 2001; 62 Suppl 20():18-25. PubMed ID: 11584871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions.
    Anton RF
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():43-53. PubMed ID: 8737000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats.
    Maurel S; De Vry J; Schreiber R
    Alcohol; 1999 Apr; 17(3):195-201. PubMed ID: 10231167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin and alcohol: interrelationships.
    Tollefson GD
    Psychopathology; 1989; 22 Suppl 1():37-48. PubMed ID: 2567040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [SSRI antidepressants and alcoholism].
    Rossinfosse C; Wauthy J; Bertrand J
    Rev Med Liege; 2000 Nov; 55(11):1003-10. PubMed ID: 11195702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of selective serotonin reuptake inhibitors.
    van Harten J
    Clin Pharmacokinet; 1993 Mar; 24(3):203-20. PubMed ID: 8384945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of serotonin selective pharmacotherapy in the treatment of alcohol dependence.
    Pettinati HM
    Alcohol Clin Exp Res; 1996 Oct; 20(7 Suppl):23A-29A. PubMed ID: 8904991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions.
    Anton RF
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):43-53. PubMed ID: 9845037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of serotonin (5-HT) and opiate-based drugs in the pharmacotherapy of alcohol dependence: an overview of the preclinical data.
    Lê AD; Tomkins DM; Sellers EM
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):27-32. PubMed ID: 9845035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study].
    Vinnikova MA; Severtsev VV; Komarov SD; Vdovin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(12):57-62. PubMed ID: 35041313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.